French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). | French ...

耶鲁大学医学院Akiko Iwasaki团队在Science Immunology上发表题为"A B cell screen against endogenous retroviruses identifies glycan-reactive IgM that recognizes a broad array of enveloped viruses的研究论文。

Studying patients with PD-1 or PD-L1 deficiency may help inform new approaches to fine-tuning immunotherapies to maximise ...

Disclosure: The author declared no competing interests. A number of monoclonal antibodies or fusion proteins directed against B-cell surface molecules and trophic factors are currently in clinical ...

Antibodies against B cells Rituximab is a depleting antibody directed against CD20 on the surface of B cells, which has established benefit in RA both with regards to clinical efficacy and ...

A small trial used designer CAR T cells to reboot the immune systems of patients with three autoimmune diseases, but it's ...

A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...

A Golden Gate-based dual-expression vector enables rapid screening, which facilitates efficient isolation of high-affinity cross-reactive antibodies for therapeutic or diagnostic use and provides a ...

Scientists have created a novel technology for developing antibody (M6P) conjugates without enzyme modification in vitro, ...

Since cancer originates within the body’s own tissue, the immune system may have difficulty identifying cancer cells as being foreign. Monoclonal antibodies supplement the body’s natural ...